title: Design of lipid nanocapsule delivery vehicles for multivalent display of recombinant Env trimers in HIV vaccination.
abstract: Immunization strategies that elicit antibodies capable of neutralizing diverse virus strains will likely be an important part of a successful vaccine against HIV. However, strategies to promote robust humoral responses against the native intact HIV envelope trimer structure are lacking. We recently developed chemically cross-linked lipid nanocapsules as carriers of molecular adjuvants and encapsulated or surface-displayed antigens, which promoted follicular helper T-cell responses and elicited high-avidity, durable antibody responses to a candidate malaria antigen. To apply this system to the delivery of HIV antigens, Env gp140 trimers with terminal his-tags (gp140T-his) were anchored to the surface of lipid nanocapsules via Ni-NTA-functionalized lipids. Initial experiments revealed that the large (409 kDa), heavily glycosylated trimers were capable of extracting fluid phase lipids from the membranes of nanocapsules. Thus, liquid-ordered and/or gel-phase lipid compositions were required to stably anchor trimers to the particle membranes. Trimer-loaded nanocapsules combined with the clinically relevant adjuvant monophosphoryl lipid A primed high-titer antibody responses in mice at antigen doses ranging from 5 μg to as low as 100 ng, whereas titers dropped more than 50-fold over the same dose range when soluble trimer was mixed with a strong oil-in-water adjuvant comparator. Nanocapsule immunization also broadened the number of distinct epitopes on the HIV trimer recognized by the antibody response. These results suggest that nanocapsules displaying HIV trimers in an oriented, multivalent presentation can promote key aspects of the humoral response against Env immunogens.
authors.affiliation: Department of Biological Engineering, #Koch Institute for Integrative Cancer Research, and ¶Department of Material Science, Engineering, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.
authors.forename: Sharmila
authors.initials: S
authors.lastname: Pejawar-Gaddy
authors.forename: James M
authors.initials: JM
authors.lastname: Kovacs
authors.forename: Dan H
authors.initials: DH
authors.lastname: Barouch
authors.forename: Bing
authors.initials: B
authors.lastname: Chen
authors.forename: Darrell J
authors.initials: DJ
authors.lastname: Irvine
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D004337:Drug Carriers / Q000737:chemistry; D000939:Epitopes / Q000276:immunology; D006678:HIV / Q000276:immunology*; D056724:Immunity, Humoral; D008055:Lipids / Q000737:chemistry*; D051379:Mice; D008970:Molecular Weight; D053769:Nanocapsules / Q000737:chemistry*; D055503:Protein Multimerization; D020836:Protein Structure, Quaternary; D011994:Recombinant Proteins / Q000737:chemistry / Q000276:immunology; D014611:Vaccination; D054299:env Gene Products, Human Immunodeficiency Virus / Q000737:chemistry* / Q000276:immunology*
chemical_list: D000956:Antigens, Viral; D004337:Drug Carriers; D000939:Epitopes; D008055:Lipids; D053769:Nanocapsules; D011994:Recombinant Proteins; D054299:env Gene Products, Human Immunodeficiency Virus